Cisatracurium Besylate

Product NDC
83634-655
11-digit product format
836340655
Labeler code
83634
Product ID
83634-655_53f69aa3-898e-476d-b18c-573487371a10
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
cisatracurium besylate
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Avenacy, LLC
Application
ANDA216539
Marketing category
ANDA
Marketing start
2026-08-15
Substance
CISATRACURIUM BESYLATE
Active strength
10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREECISATRACURIUM BESYLATEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27
A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREECISATRACURIUM BESYLATEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A216539-001AP
A216539-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-2784e616aacf4f…
2026-09-14 22:38:342026-08A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-2784e616aacf4f…
2026-08-18 06:07:402026-07A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27caaa826d4ba7…
2026-08-18 06:07:402026-07A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTION2024-08-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTION2024-08-27011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTION2024-08-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTION2024-08-2731067a03dcf5…
2025-08-23 18:47 UTC2025-08A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTION2024-08-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTION2024-08-276a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTION2024-08-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTION2024-08-27fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-2703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-2703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-272680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-272680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-275bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-275bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27d06236e962d9…
2024-10-29 15:01 UTC2024-10A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27d06236e962d9…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216539-001CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 2MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216539-002CISATRACURIUM BESYLATE PRESERVATIVE FREEEQ 10MG BASE/MLINJECTABLE / INJECTIONAP2024-08-27a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A216539-001AP184e616aacf4f…
2026-09-14 22:38:342026-08A216539-002AP184e616aacf4f…
2026-08-18 06:07:402026-07A216539-001AP1caaa826d4ba7…
2026-08-18 06:07:402026-07A216539-002AP1caaa826d4ba7…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A216539-001AP1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A216539-002AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A216539-001AP103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A216539-002AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A216539-001AP12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A216539-002AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A216539-001AP15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A216539-002AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A216539-001AP1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A216539-002AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A216539-001AP1d06236e962d9…
2024-10-29 15:01 UTC2024-10A216539-002AP1d06236e962d9…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216539-001AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216539-002AP1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Cisatracurium Besylate
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CISATRACURIUM BESYLATE10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
80YS8O1MBSInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
199212Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1c6a8b98-deac-4e25-b4a0-5d0af5090281Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cisatracurium BesylateCISATRACURIUM BESYLATEAvenacy, LLC1c6a8b98-deac-4e25-b4a0-5d0af50902812026-06-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 216539
application number: ANDA216539
ndc (product): 83634-655
Cisatracurium besylateCISATRACURIUM BESYLATESlate Run Pharmaceuticals, LLC49185e78-d244-4426-90ef-ad109824eddb2024-08-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 216539
application number: ANDA216539

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
83634-655-208363406552010 VIAL, SINGLE-DOSE in 1 CARTON (83634-655-20) / 20 mL in 1 VIAL, SINGLE-DOSE (83634-655-41) 2026-08-15NoNoCurrent